| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Blank Andrew Scott serves as a Director at BCDA. Across recent SEC filings that breaks down to 4 buys and 0 sells. Those positions are worth an estimated $793K at current prices.
Historically, Blank Andrew Scott's trades have earned a below-average insider score of 31/100 across 3 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -36.7%.
The biggest single holding is BCDA (~$793K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 634,372 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2025 | BCDA Biocardia, Inc. | Director | Buy | 288,000 | $1.25 | $360,000.00 | +83.2% | +10.3% | - | |
| Jun 30, 2025 | BCDA Biocardia, Inc. | Director | Buy | 72,289 | $2.08 | $149,999.68 | +26.4% | -28.2% | -36.4% | |
| Apr 23, 2025 | BCDA Biocardia, Inc. | Director | Buy | 131,233 | $1.91 | $249,998.87 | +97.4% | +23.5% | -37.0% | |
| Jun 19, 2020 | BCDA Biocardia, Inc. | Director | Buy | 142,850 | $2.10 | $299,985.00 | New | - | - |